Default company panoramic image
Screen 20shot 202016 10 31 20at 2010.46.07 20pm

RoverMed BioSciences

RoverMed's Ultra-Small Particle (CUSP), has the capability to bring our pharma partner's drugs right to their target no matter where the disease is in the body.

  • Stage Prototype Ready
  • Industry Nanotechnology
  • Location St Cloud, MN, US
  • Currency USD
  • Founded October 2016
  • Employees 5
  • Incorporation Type LLC
  • Website rovermed.com

Company Summary

RoverMed’s precision targeted CUSP drug delivery technology enables biologic drugs that are dependent upon new delivery systems, to target, reach, and treat diseases. Billions are spent by pharmas developing new biologic drugs, but none will actually work unless there is a delivery technology that brings drugs right to their disease target. Partnering strategy provides immediate revenue. We already have 3 signed partnerships and strong pipeline.

Team